INSIGHTS ON CONTRACT PHARMA MANUFACTURING

• Set Up And Qualify GMP Laboratories

  Eurofins PSS established and qualified a GMP microbiology lab in Ireland, providing expertise, staffing, training, and project management to ensure compliant operations and client success.

• Maximize Output From FTEs

  Eurofins PSS improved a client’s laboratory efficiency by transitioning temporary staff to full-time roles, enhancing morale, performance, and expanding their strategic partnership.

• Focus On Your Core Business Strategy

  Eurofins PSS helped a Southeast U.S. manufacturer outsource lab functions by transitioning key staff, reducing costs, and fully managing a compliant GMP QC lab program.

• Creating Equity

  Eurofins PSS provided full-time, benefit-rich staffing to replace inequitable temporary roles, creating long-term value, equity, and continuity for a major biopharma client.

• Why Fill/Finish Operations Make Or Break Viral Vector Therapies

  Discover how precision fill/finish processes ensure the safety, sterility, and success of cutting-edge viral vector therapies as they move from production to patients.

• Sterile Contract Manufacturing Selection: Aligning CGMP With Precise Product Requirements

  Partnering with an experienced sterile CMO is essential for small-batch injectables, requiring clear communication, quality alignment, and regulatory compliance to ensure manufacturing success.

• Guardians Of Precision: Regulatory Compliance And Audits For Parenteral Manufacturing Precision

  CMOs play a critical role in regulatory compliance for parenteral manufacturing, using audits, quality systems, and proactive strategies to ensure product safety and patient well-being.

• Consider Two Factors To Choose A CDMO For Developing Injectable Medicines

  Explore agile, expert CDMO services for injectable medicines, combining technical excellence and near-term availability to accelerate development and manufacturing for biopharma companies.

• Securing INmune Bio's Trial Materials In A Crisis

  Discover how a sudden biostorage shutdown put INmune Bio’s trial at risk, revealing the critical importance of logistics and rapid coordination in protecting advanced therapy programs.

• The World Outside Influencing Your Outsourcing Internals

  Tariffs, geopolitical gyrations, (pending) laws such as the BIOSECURE Act; all affect your outsourcing optionality and decision-making. Our panel of internationally savvy biopharma executives provide some guiding insights.